Trial Supports GLP-1 After Underwhelming Metabolic Surgery
Adding a GLP-1 receptor agonist to lifestyle intervention helped to bolster…
Browsing Tag
GLP1
ASA: Hold GLP-1 Agonists Before Elective Surgery
Patients on GLP-1 receptor agonists should stop taking them prior to elective…
Near 15% Weight Loss With Novel Oral GLP-1 RA in Phase II Obesity Trial
SAN DIEGO -- Orforglipron, an investigational nonpeptide GLP-1 receptor agonist, helped people with obesity lose a…
Akero Therapeutics to Present Results from Phase 2b Expansion Cohort of SYMMETRY…
SOUTH SAN FRANCISCO, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with…
Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for…
<!-- Name:DistributionId Value:8846943 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
GLP-1 RAs Safe Months After Kidney Transplant
SEATTLE -- Even for new kidney transplant recipients with diabetes, GLP-1 receptor agonists (RAs) were safe and effective,…
GLP-1 Agonists Come Out on Top in Cardiovascular Comparison of Newer Diabetes Meds
Diabetes patients adding a newcomer drug to their medications may derive cardiovascular…
Weight Loss Giants Going Head-to-Head; FDA OKs Omnipod GO; GLP-1 Drugs for Wolfram?
Eli Lilly plans to test its diabetes drug and weight loss treatment candidate tirzepatide…
Diabetes Patients Also Struggle to Access GLP-1 Agonists
Last fall, Jody Dushay, MD, an endocrinologist at Beth Israel Deaconess Medical Center in…
Trending billionaire and celebrity GLP-1 weight loss drugs are about to enter more…
Using GLP-1s drug injections for weight loss has become one of the latest ways some big names in the market are shedding extra pounds. Elon Musk recently tweeted about how using Novo…